European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Training towards Personalized Antibiotic Treatment

Resultado final

Project Website

A public project website will be created and maintained The website will have sections for researchers and the general public including upcoming events project results partner information and publications

Publicaciones

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem

Autores: Sanz Codina, M.; Gatti, M.; Troisi, C.; Fornaro, G.; Pasquini, Z.; Trapani, F.; Zanoni, A.; Caramelli, F.; Viale, P.; Pea, F.
Publicado en: Pharmaceutics, 2022, ISSN 1999-4923
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14081585

Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time–Kill Approaches

Autores: Wisse van Os; Markus Zeitlinger
Publicado en: Antibiotics, Edición 1, 2021, Página(s) 1485, ISSN 2079-6382
Editor: MDPI
DOI: 10.3390/antibiotics10121485

Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review

Autores: Sanz Codina, M.; Zeitlinger, M.
Publicado en: Clinical Pharmacokinetics, 2022, ISSN 0312-5963
Editor: Adis International Ltd.
DOI: 10.1007/s40262-021-01102-1

Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination

Autores: Maria Sanz-Codina, Sebastian G Wicha, Beatrix Wulkersdorfer, Valentin Al Jalali, Wisse Van Os, Matthias G Vossen, Martin Bauer, Edith Lackner, Christoph Dorn, Markus Zeitlinger
Publicado en: Journal of Antimicrobial Chemotherapy, 2022, ISSN 1460-2091
Editor: Oxford Academic
DOI: 10.1093/jac/dkac400

Evaluation of Th2 and Th17 Immunity-Related Factors as Indicators of Brucellosis.

Autores: Gheitasi, R.; Keramat, F.; Khosravi, S.; Hajilooi, M.; Pletz, M.; Makarewicz, O.
Publicado en: Front. Cell. Infect. Microbiol., 2022, ISSN 2235-2988
Editor: Frontiers Media S. A.
DOI: 10.3389/fcimb.2021.786994

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles